Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology - A prospective comparative study

Gynecologic Oncology

Volumn 135, Issue 2, 2014, Pages 278-284

  Schnack, Tine H ^a   Sørensen, Rie D ^a   Nedergaard, Lotte ^a   Høgdall, Claus ^a  

^a University Hospital of Copenhagen ^*  (Denmark)

Author keywords

Cancer; Fallopian tube; Ovarian; Peritoneal; Serous; Survival

Indexed keywords

ADULT; ARTICLE; ASCITES; BODY MASS; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; CLINICAL FEATURE; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MENARCHE; MULTIPARA; OVARY CARCINOMA; OVERALL SURVIVAL; PARITY; PATIENT HISTORY OF OVARIECTOMY; PERITONEUM CANCER; PREOPERATIVE CARE; PROSPECTIVE STUDY; SALPINGECTOMY; SURVIVAL TIME; UTERINE TUBE CARCINOMA; ADENOCARCINOMA; AGE DISTRIBUTION; AGED; DENMARK; FACTUAL DATABASE; FALLOPIAN TUBE NEOPLASMS; MIDDLE AGED; MORTALITY; OBESITY; OVARIAN NEOPLASMS; PATHOLOGY; PERITONEAL NEOPLASMS; PROGNOSIS;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; DATABASES, FACTUAL; DENMARK; EPIDEMIOLOGIC METHODS; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; OBESITY; OVARIAN NEOPLASMS; PARITY; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 84914102142     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.08.020     Document Type: Article

References (38)

1. M.T. Goodman, and Y.B. Shvetsov Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004 Cancer Epidemiol Biomarkers Prev 18 2009 132 139
2. H.E. Karim-Kos, V.E. de, I. Soerjomataram, V. Lemmens, S. Siesling, and J.W. Coebergh Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 2008 1345 1389
3. J.W. Carlson, A. Miron, E.A. Jarboe, M.M. Parast, M.S. Hirsch, and Y. Lee Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 2008 4160 4165
4. C.P. Crum, R. Drapkin, A. Miron, T.A. Ince, M. Muto, and D.W. Kindelberger The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 2007 3 9
5. A.L. Petri, S.K. Kjaer, I.J. Christensen, J. Blaakaer, E. Hogdall, and U. Jeppesen Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database Acta Obstet Gynecol Scand 88 2009 536 542
6. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, and J.H. Olsen The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46 1999 263 268
7. G. Pentheroudakis, and N. Pavlidis Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review Crit Rev Oncol Hematol 75 2010 27 42
8. D.J. Grant, P.G. Moorman, L. Akushevich, R.T. Palmieri, R.C. Bentley, and J.M. Schildkraut Primary peritoneal and ovarian cancers: an epidemiological comparative analysis Cancer Causes Control 21 2010 991 998
9. S.J. Jordan, A.C. Green, D.C. Whiteman, S.P. Moore, C.J. Bain, and D.M. Gertig Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis Int J Cancer 122 2008 1598 1603
10. C.M. Olsen, C.M. Nagle, D.C. Whiteman, D.M. Purdie, A.C. Green, and P.M. Webb Body size and risk of epithelial ovarian and related cancers: a population-based case-control study Int J Cancer 123 2008 450 456
11. A. Ayhan, C. Taskiran, N. Yigit-Celik, G. Bozdag, M. Gultekin, and A. Usubutun Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Int J Gynecol Cancer 16 2006 484 489
12. R. Halperin, S. Zehavi, R. Langer, E. Hadas, I. Bukovsky, and D. Schneider Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer Int J Gynecol Cancer 11 2001 403 408
13. M.A. Killackey, and A.R. Davis Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma Gynecol Oncol 51 1993 171 174
14. M.A. Merritt, P.M. De, A.F. Vitonis, L.J. Titus, D.W. Cramer, and K.L. Terry Reproductive characteristics in relation to ovarian cancer risk by histologic pathways Hum Reprod 28 2013 1406 1417
15. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, and C.M. Magnusson Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study Am J Epidemiol 156 2002 363 373
16. B. Piura, M. Meirovitz, M. Bartfeld, I. Yanai-Inbar, and Y. Cohen Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma J Surg Oncol 68 1998 173 178
17. S.M. Domchek, T.M. Friebel, S.L. Neuhausen, T. Wagner, G. Evans, and C. Isaacs Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 2006 223 229
18. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2006 185 192
19. M. Baekelandt, N.A. Jorunn, G.B. Kristensen, C.G. Trope, and V.M. Abeler Carcinoma of the fallopian tube Cancer 89 2000 2076 2084
20. A.C. Rosen, A. Reiner, M. Klein, M. Lahousen, A.H. Graf, and N. Vavra Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma Gynecol Oncol 53 1994 307 313
21. S.L. Wethington, T.J. Herzog, V.E. Seshan, N. Bansal, P.B. Schiff, and W.M. Burke Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer Cancer 113 2008 3298 3306
22. E. Jarboe, A. Folkins, M.R. Nucci, D. Kindelberger, R. Drapkin, and A. Miron Serous carcinogenesis in the fallopian tube: a descriptive classification Int J Gynecol Pathol 27 2008 1 9
23. J.D. Seidman, P. Zhao, and A. Yemelyanova "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol Oncol 120 2011 470 473
24. G. Ben-Baruch, E. Sivan, O. Moran, S. Rizel, J. Menczer, and D.S. Seidman Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma Gynecol Oncol 60 1996 393 396
25. J.M. Fowler, R.K. Nieberg, T.A. Schooler, and J.S. Berek Peritoneal adenocarcinoma (serous) of Mullerian type: a subgroup of women presenting with peritoneal carcinomatosis Int J Gynecol Cancer 4 1994 43 51
26. C. Kosary, and E.L. Trimble Treatment and survival for women with fallopian tube carcinoma: a population-based study Gynecol Oncol 86 2002 190 191
27. A. Rosen, M. Klein, M. Lahousen, A.H. Graf, A. Rainer, and N. Vavra Primary carcinoma of the fallopian tube - a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma Br J Cancer 68 1993 605 609
28. J.D. Bloss, M.F. Brady, S.Y. Liao, T. Rocereto, E.E. Partridge, and D.L. Clarke-Pearson Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - a Gynecologic Oncology Group Study Gynecol Oncol 89 2003 148 154
29. K.N. Moore, K.M. Moxley, A.N. Fader, A.E. Axtell, R.P. Rocconi, and L.N. Abaid Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary Gynecol Oncol 107 2007 398 403
30. I. Cass, C. Holschneider, N. Datta, D. Barbuto, A.E. Walts, and B.Y. Karlan BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol 106 2005 1327 1334
31. M. Chivukula, L.A. Niemeier, R. Edwards, M. Nikiforova, G. Mantha, and K. McManus Carcinomas of distal fallopian tube and their association with tubal intraepithelial carcinoma: do they share a common "precursor" lesion? Loss of heterozygosity and immunohistochemical analysis using PAX 2, WT-1, and P53 markers ISRN Obstet Gynecol 2011 2011 858647
32. A. Hashi, T. Yuminamochi, S. Murata, H. Iwamoto, T. Honda, and K. Hoshi Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum Int J Gynecol Pathol 22 2003 374 377
33. M.Q. Lacy, L.C. Hartmann, G.L. Keeney, S.C. Cha, H.S. Wieand, and K.C. Podratz c-erbB-2 and p53 expression in fallopian tube carcinoma Cancer 75 1995 2891 2896
34. R.T. Marquez, K.A. Baggerly, A.P. Patterson, J. Liu, R. Broaddus, and M. Frumovitz Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon Clin Cancer Res 11 2005 6116 6126
35. B.Y. Karlan, R.L. Baldwin, E. Lopez-Luevanos, L.J. Raffel, D. Barbuto, and S. Narod Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening Am J Obstet Gynecol 180 1999 917 928
36. E. Kuhn, R.J. Kurman, R. Vang, A.S. Sehdev, G. Han, and R. Soslow TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma - evidence supporting the clonal relationship of the two lesions J Pathol 226 2012 421 426
37. C.G. Przybycin, R.J. Kurman, B.M. Ronnett, I. Shih, and R. Vang Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34 2010 1407 1416
38. L.C. Horn, S. Kafkova, K. Leonhardt, C. Kellner, and J. Einenkel Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas Int J Gynecol Pathol 32 2013 339 344